FdaApplication

ANDA 219721

Back to search

Identifiers

Properties

PropertyValue
applicant_nameANNORA PHARMA PRIVATE LTD
application_typeANDA
approval_date2025-10-02

Products (4)

ProductActive ingredientStrengthDosage form
MIRTAZAPINEMIRTAZAPINE45MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE15MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE7.5MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE30MGTABLET;ORAL

4 products